Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.15.6071

Association of Rs11615 (C>T) in the Excision Repair Cross-complementing Group 1 Gene with Ovarian but not Gynecological Cancer Susceptibility: a Meta-analysis  

Ma, Yong-Jun (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University)
Feng, Sheng-Chun (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University)
Hu, Shao-Long (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University)
Zhuang, Shun-Hong (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University)
Fu, Guan-Hua (Clinical Laboratory, Jinhua Central Hospital, Jinhua Hospital of Zhejiang University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.15, 2014 , pp. 6071-6074 More about this Journal
Abstract
Background: Evidence suggests that the rs11615 (C>T) polymorphism in the ERCC1 gene may be a risk factor for gynecological tumors. However, results have not been consistent. Therefore we performed this meta-analysis. Methods: Eligible studies were identified by search of PubMed, MEDLINE and Chinese National Knowledge Infrastructure (CNKI). Odds ratios (ORs) and 95% confidence intervals (CIs) were applied to assess associations between rs11615 (C>T) and gynecological tumor risk. Heterogeneity among studies was tested and sensitivity analysis was applied. Results: A total of 6 studies were identified, with 1,766 cases and 2,073 controls. No significant association was found overall between rs11615 (C>T) polymorphism and gynecological tumors susceptibility in any genetic model. In further analysis stratified by cancer type, significantly elevated ovarian cancer risk was observed in the homozygote and recessive model comparison (TT vs. CC: OR=1.69, 95% CI=1.03-2.77, heterogeneity=0.876; TT vs. CT/CC: OR=1.72, 95% CI=1.07-2.77, heterogeneity=0.995). Conclusion: The results of the present meta-analysis suggest that there is no significant association between the rs11615 (C>T) polymorphism and gynecological tumor risk, but it had a increased risk in ovarian cancer.
Keywords
ERCC1; polymorphism; gynecological tumor; ovarian cancer; meta-analysis;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Begg CB and Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.   DOI   ScienceOn
2 Chen M, Kamat AM, Huang M, et al (2007). High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis, 28, 2160-5.   DOI   ScienceOn
3 Chen P, Wiencke J, Aldape K, et al (2000). Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev, 9, 843-7.
4 Cheng L, Eicher SA, Guo Z, et al (1998). Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev, 7, 465-8.
5 DerSimonian R and Kacker R (2007). Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials, 28, 105-14.   DOI   ScienceOn
6 Doherty JA, Weiss NS, Fish S, et al (2011). Polymorphisms in nucleotide excision repair genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev, 20, 1873-82.   DOI   ScienceOn
7 Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI   ScienceOn
8 Friedberg EC (2001). How nucleotide excision repair protects against cancer. Nat Rev Cancer, 1, 22-33.   DOI   ScienceOn
9 Goode EL, Ulrich CM and Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1513-30.
10 Guo SW and Thompson EA (1992). Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics, 48, 361-72.   DOI   ScienceOn
11 Han SS, Kim JW, Lee SH, et al (2012). ERCC1 C19007T polymorphism and the risk and invasiveness of cervical cancer in Korean women. Asia Pac J Clin Oncol, 8, 63-7.   DOI
12 He SY, Xu L, Niu G, et al (2012). Predictive value of excision repair cross-complementing rodent repair deficiency complementation group 1 and ovarian cancer risk. Asian Pac J Cancer Prev, 13, 1799-802.   과학기술학회마을   DOI
13 He X, Chang S, Zhang J, et al (2008). MethyCancer: the database of human DNA methylation and cancer. Nucleic Acids Res, 36, 836-41.
14 Hiyama T, Yoshihara M, Tanaka S, et al (2007). Genetic polymorphisms and esophageal cancer risk. Int J Cancer, 121, 1643-58.   DOI   ScienceOn
15 Hoeijmakers JH (2001). Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-74.   DOI   ScienceOn
16 Jo H, Kang S, Kim SI, et al (2007). The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study. Gynecol Obstet Invest, 64, 84-8.   DOI   ScienceOn
17 Lau J, Ioannidis JP and Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6.   DOI   ScienceOn
18 Li FY, Ren XB, Xie XY, et al (2013). Meta-analysis of excision repair cross-complementation group 1 (ERCC1) association with response to platinum-based chemotherapy in ovarian cancer. Asian Pac J Cancer Prev, 14, 7203-6.   과학기술학회마을   DOI   ScienceOn
19 Luo KQ, Mu SQ, Wu ZX, et al (2013). Polymorphisms in DNA repair genes and risk of glioma and meningioma. Asian Pac J Cancer Prev, 14, 449-52.   과학기술학회마을   DOI   ScienceOn
20 Mantel N and Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
21 Park JY, Lee SY, Jeon HS, et al (2002). Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev, 11, 23-7.
22 Marin MS, Lopez-Cima MF, Garcia-Castro L, et al (2004). Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev, 13, 1788-93.
23 Matullo G, Guarrera S, Sacerdote C, et al (2005). Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev, 14, 2569-78.   DOI   ScienceOn
24 Mort R, Mo L, McEwan C, et al (2003). Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer, 89, 333-7.   DOI   ScienceOn
25 Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, et al (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem, 73, 39-85.   DOI   ScienceOn
26 Shin A, Lee KM, Ahn B, et al (2008). Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev, 9, 501-5.
27 Sturgis EM, Dahlstrom KR, Spitz MR, et al (2002). DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg, 128, 1084-8.   DOI
28 Weiss JM, Weiss NS, Ulrich CM, et al (2005). Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev, 14, 2524-30.   DOI
29 Xiong Y, Gu J, Zeng L, et al (2010). Association analysis between the DNA repair gene ERCC1 c19007t polymorphism and the pathogenesis of cervical cancer. JPractical Obstetrics and Gynecology, 26, 286-9.
30 Zhou W, Liu G, Park S, et al (2005). Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev, 14, 491-6.   DOI
31 Dunlop MG, Farrington SM, Carothers AD, et al (1997). Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet, 6, 105-10.   DOI   ScienceOn